TransMedics (TMDX) Gross Profit (2018 - 2026)

TransMedics' Gross Profit history runs 9 years deep, the most recent figure standing at $101.2 million for Q1 2026.

• On a quarterly basis, Gross Profit rose 14.66% year-over-year to $101.2 million in Q1 2026; TTM through Mar 2026 was $375.7 million, a 29.41% increase from a year earlier, with the FY2025 full-year figure at $362.8 million, up 38.43% from the prior year.
• Gross Profit rose to $101.2 million in Q1 2026 per TMDX's latest filing, from $93.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $101.2 million in Q1 2026 and bottomed at $12.1 million in Q1 2022.
• The 5-year median for Gross Profit is $60.0 million (2024), against an average of $55.6 million.
• Across the five-year window, Gross Profit jumped 380.12% in 2022 and increased 14.66% in 2026, its largest moves.
• Year by year, Gross Profit stood at $20.7 million in 2022, then soared by 131.48% to $47.9 million in 2023, then soared by 50.27% to $72.0 million in 2024, then advanced by 29.72% to $93.4 million in 2025, then grew by 8.29% to $101.2 million in 2026.
• Per Business Quant, the three latest TMDX Gross Profit figures stand at $101.2 million (Q1 2026), $93.4 million (Q4 2025), and $84.6 million (Q3 2025).